Literature DB >> 1425125

Gut hormones and diabetes mellitus.

W Creutzfeldt1, M Nauck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1425125     DOI： 10.1002/dmr.5610080206

Source DB:  PubMed          Journal:  Diabetes Metab Rev        ISSN： 0742-4221


× No keyword cloud information.
  36 in total

1.  Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors.

Authors:  Frédéric Preitner; Mark Ibberson; Isobel Franklin; Christophe Binnert; Mario Pende; Asllan Gjinovci; Tanya Hansotia; Daniel J Drucker; Claes Wollheim; Rémy Burcelin; Bernard Thorens
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

2.  Do insulinotropic glucose-lowering drugs do more harm than good? The hypersecretion hypothesis revisited.

Authors:  I Rustenbeck; S Baltrusch; M Tiedge
Journal:  Diabetologia       Date:  2010-07-01       Impact factor: 10.122

3.  To be or not to be--an incretin or enterogastrone?

Authors:  M Horowitz; M A Nauck
Journal:  Gut       Date:  2006-02       Impact factor: 23.059

Review 4.  Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

Authors:  M A Nauck; I Vardarli; C F Deacon; J J Holst; J J Meier
Journal:  Diabetologia       Date:  2010-09-25       Impact factor: 10.122

Review 5.  Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins.

Authors:  Marzieh Salehi; Benedikt A Aulinger; David A D'Alessio
Journal:  Endocr Rev       Date:  2008-02-21       Impact factor: 19.871

6.  The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes.

Authors:  Heba M Ismail; Ping Xu; Ingrid M Libman; Dorothy J Becker; Jennifer B Marks; Jay S Skyler; Jerry P Palmer; Jay M Sosenko
Journal:  Diabetologia       Date:  2017-09-27       Impact factor: 10.122

7.  Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) [7-36 amide] in the fasting state in healthy subjects.

Authors:  C Qualmann; M A Nauck; J J Holst; C Orskov; W Creutzfeldt
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

8.  Evidence that glucagon stimulates insulin secretion through its own receptor in rats.

Authors:  K Kawai; C Yokota; S Ohashi; Y Watanabe; K Yamashita
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

Review 9.  Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function?

Authors:  Juris J Meier; Michael A Nauck
Journal:  Diabetes       Date:  2010-05       Impact factor: 9.461

10.  Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function.

Authors:  Annemarie M Simonis-Bik; Giel Nijpels; Timon W van Haeften; Jeanine J Houwing-Duistermaat; Dorret I Boomsma; Erwin Reiling; Els C van Hove; Michaela Diamant; Mark H H Kramer; Robert J Heine; J Antonie Maassen; P Eline Slagboom; Gonneke Willemsen; Jacqueline M Dekker; Elisabeth M Eekhoff; Eco J de Geus; Leen M 't Hart
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.